- Home
- TARS vs CLOV Comparison
TARS vs CLOV Comparison
Compare TARS & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- CLOV
- Stock Information
- Founded
- TARS 2016
- CLOV 2014
- Country
- TARS United States
- CLOV United States
- Employees
- TARS N/A
- CLOV N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- CLOV Medical Specialities
- Sector
- TARS Health Care
- CLOV Health Care
- Exchange
- TARS Nasdaq
- CLOV Nasdaq
- Market Cap
- TARS 1.7B
- CLOV 1.5B
- IPO Year
- TARS 2020
- CLOV N/A
- Fundamental
- Price
- TARS $40.00
- CLOV $2.90
- Analyst Decision
- TARS Strong Buy
- CLOV Strong Buy
- Analyst Count
- TARS 7
- CLOV 3
- Target Price
- TARS $67.14
- CLOV $4.83
- AVG Volume (30 Days)
- TARS 522.7K
- CLOV 9.8M
- Earning Date
- TARS 08-11-2025
- CLOV 08-05-2025
- Dividend Yield
- TARS N/A
- CLOV N/A
- EPS Growth
- TARS N/A
- CLOV N/A
- EPS
- TARS N/A
- CLOV N/A
- Revenue
- TARS $233,674,000.00
- CLOV $1,486,540,000.00
- Revenue This Year
- TARS $122.94
- CLOV $38.62
- Revenue Next Year
- TARS $44.14
- CLOV $22.21
- P/E Ratio
- TARS N/A
- CLOV N/A
- Revenue Growth
- TARS 449.03
- CLOV 15.62
- 52 Week Low
- TARS $20.08
- CLOV $1.50
- 52 Week High
- TARS $57.28
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- TARS 42.88
- CLOV 45.70
- Support Level
- TARS $39.41
- CLOV $2.90
- Resistance Level
- TARS $43.33
- CLOV $3.54
- Average True Range (ATR)
- TARS 1.67
- CLOV 0.19
- MACD
- TARS -0.06
- CLOV -0.01
- Stochastic Oscillator
- TARS 13.97
- CLOV 5.93
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.